Sheffner v. Gallo

515 F.2d 1169, 185 U.S.P.Q. (BNA) 726, 1975 CCPA LEXIS 157
CourtCourt of Customs and Patent Appeals
DecidedMay 15, 1975
DocketPatent Appeal No. 75-512
StatusPublished
Cited by1 cases

This text of 515 F.2d 1169 (Sheffner v. Gallo) is published on Counsel Stack Legal Research, covering Court of Customs and Patent Appeals primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Sheffner v. Gallo, 515 F.2d 1169, 185 U.S.P.Q. (BNA) 726, 1975 CCPA LEXIS 157 (ccpa 1975).

Opinions

BALDWIN, Judge.

Sheffner, the senior party, appeals from that portion of the decision of the Board of Patent Interferences which awarded priority of the sole count in issue to none of the parties involved.1 In the words of the board, priority was awarded “against” each party. Gallo and Sheffner (Gallo et al.), the junior party, did not appeal to this court from the decision of the board. We reverse.

The Subject Matter

The sole count, which is self-explanatory, reads:

A process for treating acne comprising: (1) applying to the acne affected skin of a person suffering therefrom, an acne alleviating amount of a topical composition containing 0.1 to 10% by weight of thioglycolic acid or a phar-maceutically acceptable salt thereof, and (2) keeping said composition in contact with the affected skin.

The Record2

Sheffner took no testimony, but relied on his April 4, 1969 filing date. Gallo et [1171]*1171al. took testimony and introduced evidence to prove prior actual reduction to practice. The testimony includes that of one of the alleged co-inventors, Gallo, and Carnahan, who was, at the time his deposition was taken, the Director of Patents at Mead Johnson & Company, the assignee of Gallo’s interest in the Gallo et al. application. Gallo had worked with Sheffner, who was Gallo’s immediate supervisor at Mead Johnson from 1958 until Sheffner’s resignation from Mead Johnson in 1968.

In February of 1969, Carnahan prepared a draft of a patent application pertaining to processes for treating acne through the topical application of various compounds. The draft contained no disclosure of a specific compound on which the present count would read. A copy of the draft was sent to Sheffner on February 28, 1969.

On March 6, 1969, Carnahan prepared a memorandum concerning a telephone conversation he had with Sheffner that day relating to the draft mailed to Sheffner. The memorandum reads:

Dr. Sheffner telephoned to comment on the draft patent application which was mailed to him February 28, 1969. He was quite agreeable to the content and form and in fact had no comments to offer in the way of corrections. I indicated to him that we felt it advisable to broaden the scope of the application to include thioglycolic acid and related compounds since we have always thought of this as being an equivalent of acetylcysteine for uses of this type in view of our experience with the hair-waving use. He indicated that he preferred that I would not include that in the present application since he had left no records at Mead Johnson with respect to the use of thioglycolic acid in acne and that it was something he thought he might work on himself in his present position. I agreed not to include it in this patent application in view of his remark but indicated that we considered thioglycolic acid in this use as Mead Johnson’s property and that if he pursued his plans, including the filing of a patent application, that it would lead to difficulty. We did not pursue the point any further, but he did ask if John Lanahan would be in a position to file a patent application for him from Mead Johnson’s standpoint. I assured him that Mr. Lanahan had no further connection with the company, and that if he wished to contact him to file a patent application, that was his business. We left the matter that I would make some editorial corrections to the present draft application and return it to him for execution sometime next week. He was agreeable to this.

Subsequently, the draft sent to Sheff-ner was revised by Carnahan to include the subject matter of the present count. This final revised application, which corresponds exactly to the involved Gallo et al. application, was signed by Gallo and on March 25, 1969, was sent to Sheffner for his signature. On April 8, 1969, four days after filing his involved application, Sheffner wrote a letter to Carnahan stating that he was returning the final revised application unsigned and that he was doing so on the advice of counsel.

The Board Decision

After noting that Gallo et al. had the burden of establishing priority by a preponderance of the evidence, the board held that Gallo et al. had failed to prove conception of the subject matter of the count prior to Sheffner’s filing date and were thus not entitled to an award of priority. For the sake of completeness, the board further held that the record failed to show any actual reduction to practice by Gallo et al.

With regard to not awarding priority to Sheffner, the board stated:

Our opinion supra, however, does not dispose of the case. Under the unusual circumstances involved, we cannot award priority to Sheffner, based on the record before us. For reasons given above, we have held [1172]*1172that Sheffner is not a joint inventor with Gallo; however, neither is Sheff-ner an original and independent inventor [emphasis ours] which he must be in order to prevail. The draft patent application corresponding to the involved Gallo et al. application disclosing the invention of the count was prepared at Mead Johnson prior to the Sheffner filing date. At this juncture, we note that on March 6, 1969, Sheff-ner was apprised ... of the plans at Mead Johnson relative to the concept of TGA [thioglycolic acid] for the treatment of acne. Further, the draft patent application was forwarded to Sheffner on March 25, 1969 and Sheffner admits retaining a copy of said patent application for at least some period after April 8, 1969. In the interim, the involved Sheffner application was precipitously filed on April . 4, 1969. [Emphasis theirs.] From the time Sheffner left Mead Johnson on September 22, 1968 until April 4, 1969, we find not a shred of evidence demonstrating any activity on the part of Sheffner with regard to the specific subject matter of the count in issue. With this record before us, we cannot reward Sheffner merely for the reason that he filed his application post haste after seeing the application of his opponent in this interference and thereby became senior party herein.

Opinion

Upon analyzing the decision below, we can only come to the conclusion that the board, in awarding priority “against” Sheffner, violated one of the most basic principles of interference law —“an interference is limited to a determination of priority and questions ‘ancillary’ thereto.” Mortsell v. Laurila, 301 F.2d 947, 49 CCPA 1028 (1962). See Rule 258, 37 CFR 1.258. The board clearly based its decision relating to Sheffner only3 upon its determination that someone other than Sheffner was the “original and independent inventor” of the subject matter of the count, i. e., third party inventorship, and such a determination is not “ancillary” to priority. Mortsell v. Laurila, supra. Basing its decision upon such a determination is reversible error. Furthermore, evidence or lack of evidence as to the issue of third party inventorship is not pertinent to the issue of priority between the parties in a two-party interference, Mortsell v. Laurila, supra.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

John E. Morgan v. Harry Hirsch
728 F.2d 1449 (Federal Circuit, 1984)

Cite This Page — Counsel Stack

Bluebook (online)
515 F.2d 1169, 185 U.S.P.Q. (BNA) 726, 1975 CCPA LEXIS 157, Counsel Stack Legal Research, https://law.counselstack.com/opinion/sheffner-v-gallo-ccpa-1975.